At a glance
ClinicalIndex Comparison RecordN/ACompleted· 51 enrolled
Drug / intervention
esomeprazole+amox+levo+tetra +1 moredrug
Likely dose
esomeprazole+amox+levo+tetra 40 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Comparison of Two Rescue Therapies for Helicobacter Pylori Infection - A Multicenter Randomized Controlled Trial
In Brief
A clinical study evaluating esomeprazole+amox+levo+tetra and esomeprazole+amox+levo for Helicobacter Pylori Infection. Completed, enrolled 51 participants across 1 site.
Detailed Summary
From the profiles of antibiotic susceptibility data following eradication therapy, tetracycline, amoxicillin and levofloxacin are all good candidates of antibiotics used in the rescue treatment.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHelicobacter Pylori Infection
CountriesTaiwan
Timeline
N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
Enrollment StartNov 2013
First PostedSep 2015
Primary CompletionJul 2017
Study CompletionOct 2017
TodayJul 2026
First PostedSep 11, 2015
Enrollment StartNov 1, 2013
Primary CompletionJul 1, 2017
Study CompletionOct 1, 2017
TodayJul 2, 2026
Enrollment to primary: 3.7 yearsPosted 10.8 years ago
Interventions
esomeprazole+amox+levo+tetradrug
esomeprazole 40 mg b.d., amoxicillin 500 mg q.d.s., levofloxacin 500 mg o.d., and tetracycline 500 mg q.d.s.
esomeprazole+amox+levodrug
esomeprazole 40 mg b.d., amoxicillin 500 mg q.d.s., levofloxacin 500 mg o.d.,